Products
Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

Vitamin B12 test kit

KD-026

Cat. No.: 0225LY-1242
Appearance: Solid
Purity: ≥99%
Identity: Confirmed by LC-MS.
Size:
KD-026
Add to basket

Product Overview

Description: KD-026 is a microsomal triglyceride transfer protein (MTP) inhibitor (IC50: 8.0 nM) currently utilized in studies related to type 2 diabetes.
Synonym: SLx 4090; SLx4090;KD026; SLx-4090; 913541-47-6; KD-026; 2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-6-[[[6-methoxy-4'-(trifluoromethyl)[1,1'-biphenyl]-2-yl]carbonyl]amino]-, phenyl ester; Phenyl 6-[[3-methoxy-2-[4-(trifluoromethyl)phenyl]benzoyl]amino]-3,4-dihydro-1H-isoquinoline-2-carboxylate; 2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-6-(((6-methoxy-4'-(trifluoromethyl)(1,1'-biphenyl)-2-yl)carbonyl)amino)-, phenyl ester; Phenyl 6-((3-methoxy-2-(4-(trifluoromethyl)phenyl)benzoyl)amino)-3,4-dihydro-1H-isoquinoline-2-carboxylate; Phenyl 6-(6-methoxy-4'-(trifluoromethyl)-(1,1'-biphenyl)-2-amido)-1,2,3,4-tetrahydroisoquinoline-2-carboxylate
CAS No.: 913541-47-6
Compound CID: 53497429
Formula: C31H25F3N2O4
Formula Weight: 546.54

Specification

Targets&IC50: ApoB: 9.6 nM; MTP: 8.0 nM
Stability: 3 years in powder form.
Storage: Storage at -20°C.
Applications: KD-026 can be used in lipid signaling research to investigate the specific inhibition of triglyceride-related metabolic pathways.

Library Information

Target: MTP
Receptor: MTTP
Pathways: Metabolism
Plate Number: AOCL-16
Plate Location: h9
Empty Location: a1-h1; a12-h12
Container: 96-well plate
Formulation: 10mM DMSO
DMSO Max Solubility: 55 mg/mL; 100.63 mM
Inquiry
0
Inquiry Basket

Copyright © Protheragen. All rights reserves.